Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$253M |
| 2 |
ETHA
iShares Ethereum Trust ETF
ETHA
|
+$186M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$131M |
| 4 |
Broadcom
AVGO
|
+$110M |
| 5 |
Union Pacific
UNP
|
+$104M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fidelity Wise Origin Bitcoin Fund
FBTC
|
+$247M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$109M |
| 3 |
Caterpillar
CAT
|
+$109M |
| 4 |
Applovin
APP
|
+$93.9M |
| 5 |
Apple
AAPL
|
+$72.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.11% |
| 2 | Industrials | 11.26% |
| 3 | Healthcare | 8.5% |
| 4 | Financials | 8.16% |
| 5 | Consumer Discretionary | 6.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AARD
776
Aardvark Therapeutics
AARD
$151M
| $3.37M | 0.02% |
253,752
-25,506
| -9% | -$288K |
|
777
Fulcrum Therapeutics
FULC
$293M
| $3.37M | 0.02% |
366,303
+161,903
| +79% | +$1.17M |
|
778
Newmark Group
NMRK
$2.91B
| $3.36M | 0.02% |
180,125
+50,261
| +39% | +$816K |
|
779
CALL
Intel
INTC
$461B
| $3.35M | 0.02% |
+100,000
| New | +$2.42M |
|
780
Cardinal Health
CAH
$54B
| $3.35M | 0.02% |
21,352
-45,743
| -68% | -$7.07M |
|
781
Zscaler
ZS
$28.5B
| $3.35M | 0.02% |
11,181
-16,039
| -59% | -$4.57M |
|
|
BACCU
782
Blue Acquisition Corp Unit
BACCU
| $3.35M | 0.02% |
299,332
-404,604
| -57% | -$4.08M |
|
|
GAP
783
The Gap Inc
GAP
$7.33B
| $3.35M | 0.02% |
156,571
+25,539
| +19% | +$552K |
|
784
Amdocs
DOX
$6.48B
| $3.34M | 0.02% |
40,729
+24,624
| +153% | +$2.13M |
|
785
Occidental Petroleum
OXY
$60.1B
| $3.33M | 0.02% |
70,570
+67,270
| +2,038% | +$3.04M |
|
786
Skyward Specialty Insurance
SKWD
$2.35B
| $3.33M | 0.02% |
+69,918
| New | +$3.5M |
|
787
United Parks & Resorts
PRKS
$2.03B
| $3.3M | 0.02% |
63,847
+13,139
| +26% | +$662K |
|
788
CALL
Amazon
AMZN
$2.83T
| $3.29M | 0.02% |
15,000
-65,000
| -81% | -$14.7M |
|
789
Churchill Downs
CHDN
$6.32B
| $3.29M | 0.02% |
33,907
+4,354
| +15% | +$448K |
|
790
Republic Services
RSG
$68.3B
| $3.29M | 0.02% |
14,321
-15,733
| -52% | -$3.69M |
|
791
Prime Medicine
PRME
$589M
| $3.29M | 0.02% |
593,039
-225,479
| -28% | -$916K |
|
792
Denali Therapeutics
DNLI
$3.87B
| $3.28M | 0.02% |
+226,203
| New | +$3.25M |
|
793
Inhibrx
INBX
$1.54B
| $3.28M | 0.02% |
97,382
-57,408
| -37% | -$1.41M |
|
|
CHAC
794
DELISTED
Crane Harbor Acquisition Corp
CHAC
| $3.28M | 0.02% |
323,223
-146,777
| -31% | -$1.47M |
|
795
Conagra Brands
CAG
$8B
| $3.27M | 0.02% |
178,462
-394,444
| -69% | -$7.56M |
|
796
Kimberly-Clark
KMB
$37B
| $3.26M | 0.02% |
26,256
-2,725
| -9% | -$352K |
|
797
Kiniksa Pharmaceuticals
KNSA
$6.19B
| $3.26M | 0.02% |
83,881
+15,130
| +22% | +$492K |
|
|
FERA
798
Fifth Era Acquisition Corp I
FERA
$330M
| $3.25M | 0.02% |
319,630
-290,331
| -48% | -$2.95M |
|
799
Global Payments
GPN
$25B
| $3.25M | 0.02% |
39,144
+22,776
| +139% | +$1.92M |
|
800
Commercial Metals
CMC
$7.18B
| $3.24M | 0.02% |
56,624
+51,121
| +929% | +$2.82M |
|
Similar funds
Steve Schonfeld's Q3 2025 Portfolio in Review
As of Q3 2025, Steve Schonfeld held 2,706 positions worth $17.6B, up 20% from $14.7B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Steve Schonfeld deployed $1.8B of net new capital in Q3 2025, opening 730 new positions and adding to 658 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 202,655 shares worth $136M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 15% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Fidelity Wise Origin Bitcoin Fund, an estimated $247M trimmed.
- Steve Schonfeld's largest Q3 2025 buy was iShares Core S&P 500 ETF: 202,655 shares worth $136M.
- Steve Schonfeld added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $253M increase.
- Steve Schonfeld's biggest Q3 2025 reduction was Fidelity Wise Origin Bitcoin Fund, cutting an estimated $247M.
- Steve Schonfeld fully exited Morgan Stanley in Q3 2025, selling an estimated $55.6M.
- Steve Schonfeld's ten largest holdings make up 26% of its $17.6B portfolio in Q3 2025.
- Steve Schonfeld opened 730 new positions and closed 555 in Q3 2025.
- Steve Schonfeld's portfolio value rose 20% quarter-over-quarter to $17.6B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.